J.carl Barrett

J. Carl Barrett is currently serving as the Chief Scientific Officer at Precede Biosciences and a Professor at the University of North Carolina, focusing on independent research related to cancer development and treatment, particularly the role of inflammation in cancer and aging. As a biotech consultant through JCarl Consulting, LLC, J. Carl Barrett leverages 17 years of experience in drug development, specializing in translational medicine and diagnostics. Previous positions include Vice President of Translational Medicine for Oncology at AstraZeneca and Vice President and Global Head of Biomarkers and Imaging at Novartis, along with a directorship at the Center for Cancer Research at the National Institutes of Health. J. Carl Barrett earned a Ph.D. in Biophysical Chemistry from Johns Hopkins University and a degree in Chemistry and Mathematics from the College of William and Mary.